Adam S Cheifetz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Adam S Cheifetz

Showing results (201-210 of 203) with videos related to

Pageof 21

Sort By:

You have reached the last page of results.This site can display upto 203 results.

The Lancet. Gastroenterology & Hepatology|January 13, 2022

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectivesKonstantinos Papamichael, Waqqas Afif, David Drobne, et al.

Science Translational Medicine|January 12, 2018

Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn's disease and Parkinson's diseaseKen Y Hui, Heriberto Fernandez-Hernandez, Jianzhong Hu, et al.

Gastroenterology|July 6, 2016

A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSFLing-Shiang Chuang, Nicole Villaverde, Ken Y Hui, et al.

Pageof 21

Search research articles

Showing results (201-210 of 203) with videos related to

Sort By:

Pageof 21

You have reached the last page of results.This site can display upto 203 results.

The Lancet. Gastroenterology & Hepatology|January 13, 2022

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectivesKonstantinos Papamichael, Waqqas Afif, David Drobne, et al.

Science Translational Medicine|January 12, 2018

Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn's disease and Parkinson's diseaseKen Y Hui, Heriberto Fernandez-Hernandez, Jianzhong Hu, et al.

Gastroenterology|July 6, 2016

A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSFLing-Shiang Chuang, Nicole Villaverde, Ken Y Hui, et al.

Pageof 21